期刊文献+

SELECTION AND THEIR ANTITUMOR ACTIVITY OF ANTISENSE OLIGONUCLEOTIDES TARGETING MESSENGER RNA OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

SELECTION AND THEIR ANTITUMOR ACTIVITY OF ANTISENSE OLIGONUCLEOTIDES TARGETING MESSENGER RNA OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
下载PDF
导出
摘要 Objective: To select the antisense oligonucleotides (asONs) which hybridize with the mRNA of vascular endothelial growth factor receptor2 (VEGFR2, also named as kinase insert domain-containing receptor:KDR) in an effective and specific way, and to investigate their antitumor activity in MCF-7 cells. Methods: The effective antisense oligonucleotides were chosen by computer prediction combined with oligonucleotide microarrays. The inhibition effect on MCF-7 cells proliferation was measured by MTT; and VEGFR2 expression was surveyed by Western-blotting and RT- PCR. Results: Using predicting secondary structure of VEGFR2 mRNA with RNA folding program, computer prediction designed 30 antisense oligonucleotide probes that were directed to local loose regions of RNA structure. In 30 probes, 4(4/30, 13.33%) antisense oligonucleotides showed strong hybridization intensities in oligonucleotide microarrays test and were selected. All these antisense oligonucleotides targeting 4 different sites of VEGFR2 mRNA lowered the level of VEGFR2 mRNA and protein present in MCF-7 cells. Proliferation of MCF-7 cells was reduced by 4 antisense oligonucleotides, respectively, in which asON1 was the most effective, with the inhibitory rates being 53.06% at 0.8 I.tmol/L. Conclusion: Combination of computer prediction with oligonucleotide microarrays is an effective way in selecting optimal antisense oligonucleotides. The antisense oligonucleotides showed good correlation between their antitumor activity and the hybridization intensities. The antisense oligonucleotides targeting VEGFR2 mRNA demonstrated prominent antitumor role in vitro. Objective: To select the antisense oligonucleotides (asONs) which hybridize with the mRNA of vascular endothelial growth factor receptor2 (VEGFR2, also named as kinase insert domain-containing receptor:KDR) in an effective and specific way, and to investigate their antitumor activity in MCF-7 cells. Methods: The effective antisense oligonucleotides were chosen by computer prediction combined with oligonucleotide microarrays. The inhibition effect on MCF-7 cells proliferation was measured by MTT; and VEGFR2 expression was surveyed by Western-blotting and RT- PCR. Results: Using predicting secondary structure of VEGFR2 mRNA with RNA folding program, computer prediction designed 30 antisense oligonucleotide probes that were directed to local loose regions of RNA structure. In 30 probes, 4(4/30, 13.33%) antisense oligonucleotides showed strong hybridization intensities in oligonucleotide microarrays test and were selected. All these antisense oligonucleotides targeting 4 different sites of VEGFR2 mRNA lowered the level of VEGFR2 mRNA and protein present in MCF-7 cells. Proliferation of MCF-7 cells was reduced by 4 antisense oligonucleotides, respectively, in which asON1 was the most effective, with the inhibitory rates being 53.06% at 0.8 I.tmol/L. Conclusion: Combination of computer prediction with oligonucleotide microarrays is an effective way in selecting optimal antisense oligonucleotides. The antisense oligonucleotides showed good correlation between their antitumor activity and the hybridization intensities. The antisense oligonucleotides targeting VEGFR2 mRNA demonstrated prominent antitumor role in vitro.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2005年第3期161-170,共10页 中国癌症研究(英文版)
基金 This work was supported by the National Natural Sciences Foundation of China (No. 3017111) and National Project "863" (No. 2001AA234041)
关键词 Target selection Computer prediction Oligonucleotide microarrays Antisense oligonucleotide VEGFR2/KDR Target selection Computer prediction Oligonucleotide microarrays Antisense oligonucleotide VEGFR2/KDR
  • 相关文献

参考文献27

  • 1Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor [J]. Endocr Rev 1997;18:4-25.
  • 2Alon T, Hemo I, Ltin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity [J]. Nat Med 1995;1:1024-8.
  • 3Terman BI, Dougher-Vermazen M, Carrion ME, et al.Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor[J]. Biochem Biophys Res Commun 1992;187:1579-86.
  • 4Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors [J]. Cytokine Growth Factor Rev 1996; 7:259-70.
  • 5Zhang H, Li Y, Li H, et al. Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2[J]. Leuk Lymphoma 2004; 45:1887-97.
  • 6Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor- positive human tumors [J].Blood 2001; 98:1904-13.
  • 7Price DJ, Miralem T, Jiang S, et al. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells[J]. Cell Growth Differ 2001; 12:129-35.
  • 8Frauendorf A, Engels JW. Interaction of linear and folded modified antisense oligonucleotides with sequences containing secondary structure elements [J].Bioorg Med Chem Lett 1994; 4:1019-24.
  • 9Zuker M. Mfold web server for nucleic acid folding and hybridization prediction [J]. Nucleic Acids Res 2003; 31:3406-15.
  • 10Milner N, Mir KU, Southern EM. Selecting effective antisense reagents on combinatorial oligonucleotide arrays [J]. Nat Biotechnol 1997; 15:537-41.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部